US5985884A
(en)
|
1996-07-01 |
1999-11-16 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
USRE39266E1
(en)
*
|
1996-07-01 |
2006-09-05 |
Dr. Reddy's Laboratories, Limited |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
US6011036A
(en)
*
|
1997-04-15 |
2000-01-04 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
|
US6369067B1
(en)
|
1997-10-27 |
2002-04-09 |
Dr. Reddy's Research Foundation |
Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
BR9812772A
(pt)
|
1997-10-27 |
2000-10-10 |
Reddy Research Foundation |
"compostos tricìclicos inéditos e o seu emprego na medicina;processo para a sua preparação e composições farmacêuticas contendo os mesmos"
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
US6265401B1
(en)
|
1997-10-27 |
2001-07-24 |
Reddy-Cheminor, Inc. |
Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
CN1280574A
(zh)
|
1997-10-27 |
2001-01-17 |
雷迪研究基金会 |
新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
|
RU2247722C2
(ru)
|
1997-10-27 |
2005-03-10 |
Др. Редди`З Лабораториз Лимитед |
Производные арилкарбоновых кислот, способы их получения, фармацевтическая композиция на их основе, способы лечения и предупреждения различных заболеваний, промежуточные соединения и способы их получения
|
AU7109798A
(en)
*
|
1997-12-02 |
1998-10-30 |
Dr. Reddy's Research Foundation |
Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypol ipidemia and antihypertensive properties
|
AU1120599A
(en)
*
|
1998-04-23 |
1999-03-08 |
Dr. Reddy's Research Foundation |
New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
|
IN187716B
(fr)
*
|
1998-09-14 |
2002-06-15 |
Reddy Research Foundation |
|
US6531596B1
(en)
|
1998-10-29 |
2003-03-11 |
Dr. Reddy's Laboratories Ltd. |
Process for the preparation of new antidiabetic agents
|
WO2000026200A1
(fr)
|
1998-10-29 |
2000-05-11 |
Dr. Reddy's Research Foundation |
Technique amelioree de preparation de nouveaux agents antidiabetiques
|
JP5524435B2
(ja)
*
|
1998-12-01 |
2014-06-18 |
ドクター レディーズ ラボラトリーズ リミティド |
新規医薬組成物及びその調製のための方法
|
CA2376919C
(fr)
*
|
1999-06-18 |
2008-11-04 |
Merck & Co., Inc. |
Derives d'arylthiazolidinedione et d'aryloxazolidinedione
|
JP2003525908A
(ja)
|
2000-03-08 |
2003-09-02 |
ノボ ノルディスク アクティーゼルスカブ |
血清脂質の低下
|
EP1939203B1
(fr)
*
|
2000-04-25 |
2014-11-19 |
ICOS Corporation |
Inhibiteurs de delta-isoforme de phosphatidyl-inositol-3-kinase humaine
|
WO2001081346A2
(fr)
*
|
2000-04-25 |
2001-11-01 |
Icos Corporation |
Inhibiteurs de la phosphatidyl-inositol 3-kinase delta humaine
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
WO2001091751A1
(fr)
*
|
2000-05-30 |
2001-12-06 |
Novo Nordisk A/S |
Nouvelle composition pharmaceutique et son procede de preparation
|
JP2004506609A
(ja)
|
2000-05-26 |
2004-03-04 |
ノボ ノルディスク アクティーゼルスカブ |
新たなる医薬組成物及びその調製の為の方法
|
US6559335B2
(en)
|
2000-09-22 |
2003-05-06 |
Dr. Reddy's Laboratories Limited |
Process for the preparation of 3-aryl-2-hydroxy propanoic acid
|
WO2002060443A1
(fr)
*
|
2000-12-18 |
2002-08-08 |
Smithkline Beecham Corporation |
Thiazolidinediones
|
DK1345895T3
(da)
|
2000-12-21 |
2007-05-07 |
Sanofi Aventis Deutschland |
Hidtil ukendt diphenylazetidioner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse til behandling af lipidstofskifteforstyrrelser
|
CA2436738A1
(fr)
*
|
2001-02-05 |
2002-08-15 |
Dr. Reddy's Laboratories Ltd. |
Sels de composes heterocycliques pharmaceutiquement acceptables
|
WO2002069994A2
(fr)
|
2001-03-07 |
2002-09-12 |
Novo Nordisk A/S |
Utilisation combinee de derives d'analogues glp-1 et de ligands ppar
|
DE10142660A1
(de)
|
2001-08-31 |
2003-03-20 |
Aventis Pharma Gmbh |
Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
|
PE20021091A1
(es)
|
2001-05-25 |
2003-02-04 |
Aventis Pharma Gmbh |
Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
|
MXPA04001328A
(es)
|
2001-08-22 |
2004-05-05 |
Aventis Pharma Gmbh |
Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
|
DE10142668A1
(de)
|
2001-08-31 |
2003-03-20 |
Aventis Pharma Gmbh |
Verwendung von C2-substituierten Indan-1-on-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
|
DE10142665B4
(de)
|
2001-08-31 |
2004-05-06 |
Aventis Pharma Deutschland Gmbh |
C2-Disubstituierte Indan-1-one und ihre Derivate
|
DE10142661B4
(de)
|
2001-08-31 |
2004-06-09 |
Aventis Pharma Deutschland Gmbh |
Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
|
DE10142659A1
(de)
|
2001-08-31 |
2003-03-20 |
Aventis Pharma Gmbh |
Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
|
US7399777B2
(en)
|
2001-08-31 |
2008-07-15 |
Sanofi-Aventis Deutschland Gmbh |
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
|
MXPA04001850A
(es)
|
2001-08-31 |
2004-06-15 |
Aventis Pharma Gmbh |
Derivados de diarilcicloalquilo, procedimientos para su preparacion y su utilizacion como agentes activadores de ppar.
|
DE10142662B4
(de)
|
2001-08-31 |
2004-07-08 |
Aventis Pharma Deutschland Gmbh |
Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
|
US6884812B2
(en)
|
2001-08-31 |
2005-04-26 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
|
DE10142667B4
(de)
|
2001-08-31 |
2004-06-09 |
Aventis Pharma Deutschland Gmbh |
C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
|
DE10142666A1
(de)
|
2001-08-31 |
2003-03-20 |
Aventis Pharma Gmbh |
Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
|
DE10142663B4
(de)
|
2001-08-31 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
C2-Disubstituierte Indan-1-ol-Systeme
|
DE10142722A1
(de)
|
2001-08-31 |
2003-03-27 |
Aventis Pharma Gmbh |
C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
JP4563675B2
(ja)
|
2001-10-12 |
2010-10-13 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
置換ピペリジン類、およびヒスタミンh3受容体関連疾患の治療のためのその使用
|
GB0124627D0
(en)
*
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
US7285557B2
(en)
|
2001-10-15 |
2007-10-23 |
Smithkline Beecham P.L.C. |
Pyrimidinones as melanin concentrating hormone receptor 1
|
US7220777B2
(en)
|
2001-10-15 |
2007-05-22 |
Smithkline Beecham P.L.C. |
Lactam derivatives as antagonists for human 11cby receptors
|
BR0215212A
(pt)
|
2001-12-21 |
2004-12-07 |
Novo Nordisk As |
Ativador de carboxamida ou sulfonamida de glicoquinase, composto, composição farmacêutica, e, uso de um composto
|
US8377950B2
(en)
*
|
2002-03-15 |
2013-02-19 |
Dr. Reddy's Laboratories Limited |
Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
|
US7078404B2
(en)
|
2002-04-11 |
2006-07-18 |
Sanofi-Aventis Deutschland Gmbh |
Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
|
US7223796B2
(en)
|
2002-04-11 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
|
US7049341B2
(en)
|
2002-06-07 |
2006-05-23 |
Aventis Pharma Deutschland Gmbh |
N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
|
US7671047B2
(en)
|
2002-06-19 |
2010-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
US7176194B2
(en)
|
2002-06-19 |
2007-02-13 |
Sanofi-Aventis Deutschland Gmbh |
Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
US7176193B2
(en)
|
2002-06-19 |
2007-02-13 |
Sanofi-Aventis Deutschland Gmbh |
Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
|
KR101116627B1
(ko)
|
2002-06-27 |
2012-10-09 |
노보 노르디스크 에이/에스 |
치료제로서 아릴 카르보닐 유도체
|
US7262220B2
(en)
|
2002-07-11 |
2007-08-28 |
Sanofi-Aventis Deutschland Gmbh |
Urea- and urethane-substituted acylureas, process for their preparation and their use
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
BR0312697A
(pt)
|
2002-07-12 |
2005-04-26 |
Aventis Pharma Gmbh |
Benzoiluréias substituìdas heterociclicamente, processo para a sua preparação e sua aplicação como medicamento
|
US7141561B2
(en)
|
2002-07-25 |
2006-11-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituted diaryl heterocycles, process for their preparation and their use as medicaments
|
US20040157922A1
(en)
|
2002-10-04 |
2004-08-12 |
Aventis Pharma Deutschland Gmbh |
Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments
|
US7208504B2
(en)
|
2002-10-12 |
2007-04-24 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic inhibitors of hormone sensitive lipase
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
US20040242583A1
(en)
|
2003-01-20 |
2004-12-02 |
Aventis Pharma Deutschland Gmbh |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
|
US7179941B2
(en)
|
2003-01-23 |
2007-02-20 |
Sanofi-Aventis Deutschland Gmbh |
Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
|
US7390814B2
(en)
|
2003-02-13 |
2008-06-24 |
Sanofi-Aventis Deutschland Gmbh |
Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
|
US7652007B2
(en)
|
2003-02-13 |
2010-01-26 |
Sanofi-Aventis Deutschland Gmbh |
Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7148246B2
(en)
|
2003-02-27 |
2006-12-12 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
|
DE10308353A1
(de)
|
2003-02-27 |
2004-12-02 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10308351A1
(de)
|
2003-02-27 |
2004-11-25 |
Aventis Pharma Deutschland Gmbh |
1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10308355A1
(de)
|
2003-02-27 |
2004-12-23 |
Aventis Pharma Deutschland Gmbh |
Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
DE10308352A1
(de)
|
2003-02-27 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
US7501440B2
(en)
|
2003-03-07 |
2009-03-10 |
Sanofi-Aventis Deutschland Gmbh |
Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
|
EP1615698B1
(fr)
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
Nouvelles amides substitues et leur utilisation pharmaceutique
|
NZ544307A
(en)
*
|
2003-06-27 |
2008-12-24 |
Reddy Research Foundation |
Compositions comprising balaglitazone and further antidiabetic compounds
|
US7094800B2
(en)
|
2003-07-25 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Cyanopyrrolidides, process for their preparation and their use as medicaments
|
US7008957B2
(en)
|
2003-07-25 |
2006-03-07 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
|
US7094794B2
(en)
|
2003-07-28 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
|
DE10335092B3
(de)
|
2003-08-01 |
2005-02-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
|
MXPA06003474A
(es)
|
2003-09-30 |
2006-06-05 |
Novo Nordisk As |
Agonistas de receptores de melanocortina.
|
ES2357801T3
(es)
|
2003-10-24 |
2011-04-29 |
Santen Pharmaceutical Co., Ltd. |
Agente terapéutico para trastorno queratoconjuntival.
|
RU2006112343A
(ru)
*
|
2003-10-28 |
2007-12-10 |
Редди Юс Терапеутикс, Инк. (Us) |
Гетероциклические соединения и способы их получения и применения
|
US7348329B2
(en)
|
2003-10-29 |
2008-03-25 |
Santen Pharmaceutical Co., Ltd. |
Therapeutic agent for keratoconjunctival disorder
|
JP2005162735A
(ja)
*
|
2003-10-29 |
2005-06-23 |
Santen Pharmaceut Co Ltd |
角結膜障害治療剤
|
EP1694356B1
(fr)
|
2003-12-09 |
2011-02-16 |
Novo Nordisk A/S |
Regulation d'une preference alimentaire au moyen d'agonistes de glp-1
|
DK1723128T3
(da)
|
2004-01-06 |
2013-02-18 |
Novo Nordisk As |
Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
|
US7498341B2
(en)
|
2004-01-31 |
2009-03-03 |
Sanofi Aventis Deutschland Gmbh |
Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
|
US7470706B2
(en)
|
2004-01-31 |
2008-12-30 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
|
US7402674B2
(en)
|
2004-01-31 |
2008-07-22 |
Sanofi-Aventis Deutschland Gmbh, |
7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
EP1586573B1
(fr)
|
2004-04-01 |
2007-02-07 |
Sanofi-Aventis Deutschland GmbH |
Oxadiazolones, procédé pour leur préparation, usage comme agents pharmaceutiques
|
JP2007536344A
(ja)
|
2004-05-04 |
2007-12-13 |
ノボ ノルディスク アクティーゼルスカブ |
新規のインドール誘導体
|
US7932260B2
(en)
|
2004-05-13 |
2011-04-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
EP1604988A1
(fr)
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Dérivés de pyridazinone, méthodes de leur préparation et leur utilisation comme pharmaceutiques
|
CN1950078A
(zh)
|
2004-06-11 |
2007-04-18 |
诺和诺德公司 |
使用glp-1激动剂抵抗药物诱发的肥胖
|
EP1841749A1
(fr)
|
2004-09-02 |
2007-10-10 |
Metabasis Therapeutics, Inc. |
Derives d'inhibiteurs de thiazole et de thiadiazoles de tyrosine phosphatases
|
JP4874989B2
(ja)
|
2004-11-22 |
2012-02-15 |
ノヴォ ノルディスク アー/エス |
可溶性で安定なインスリン含有調合物
|
CA2590720A1
(fr)
|
2004-12-03 |
2006-06-08 |
Lone Jeppesen |
Composes heteroaromatiques activants de glucokinase
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
AU2006264966B2
(en)
|
2005-07-04 |
2013-02-21 |
High Point Pharmaceuticals, Llc |
Histamine H3 receptor antagonists
|
JP4960355B2
(ja)
|
2005-07-14 |
2012-06-27 |
ノボ・ノルデイスク・エー/エス |
ウレア型グルコキナーゼ活性化剤
|
ES2426345T3
(es)
|
2005-07-20 |
2013-10-22 |
Eli Lilly And Company |
Compuesto unidos en posición 1-amino
|
JP2009509988A
(ja)
|
2005-09-29 |
2009-03-12 |
サノフィ−アベンティス |
フェニル−及びピリジニル−1,2,4−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用
|
PL1951658T3
(pl)
|
2005-11-17 |
2013-02-28 |
Lilly Co Eli |
Antagoniści receptora glukagonu, preparatyka i zastosowania terapeutyczne
|
ES2427247T3
(es)
|
2006-03-13 |
2013-10-30 |
Kyorin Pharmaceutical Co., Ltd. |
Aminoquinolonas como inhibidores de GSK-3
|
KR101280333B1
(ko)
|
2006-03-28 |
2013-07-02 |
하이 포인트 파마슈티칼스, 엘엘씨 |
히스타민 h3 수용체 활성을 갖는 벤조티아졸
|
TW200815377A
(en)
*
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
CA2659570C
(fr)
|
2006-05-29 |
2015-10-06 |
High Point Pharmaceuticals, Llc |
3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, ses sels et solvates et leur utilisation en tant qu'antagoniste du recepteur de l'histamine h3
|
DE102006028862A1
(de)
|
2006-06-23 |
2007-12-27 |
Merck Patent Gmbh |
3-Amino-imidazo[1,2-a]pyridinderivate
|
AU2007283113A1
(en)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
|
ES2377322T3
(es)
|
2006-11-15 |
2012-03-26 |
High Point Pharmaceuticals, Llc |
Nuevas 2-(2-hidroxifenil)benzotiadiazinas útiles para el tratamiento de la obesidad y la diabetes
|
ATE523497T1
(de)
|
2006-11-15 |
2011-09-15 |
High Point Pharmaceuticals Llc |
Neue 2-(2-hydroxyphenyl)benzimidazole, die sich für die behandlung von obesitas und diabetes eignen
|
AU2008204530B2
(en)
|
2007-01-11 |
2013-08-01 |
Vtv Therapeutics Llc |
Urea glucokinase activators
|
DE102007002260A1
(de)
|
2007-01-16 |
2008-07-31 |
Sanofi-Aventis |
Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms
|
DE102007005045B4
(de)
|
2007-01-26 |
2008-12-18 |
Sanofi-Aventis |
Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102007008420A1
(de)
|
2007-02-21 |
2008-08-28 |
Merck Patent Gmbh |
Benzimidazolderivate
|
US7838691B2
(en)
|
2007-04-05 |
2010-11-23 |
Board Of Regents, Of The University Of Texas System |
Palmerolides: methods of preparation and derivatives thereof
|
US20080319221A1
(en)
|
2007-06-22 |
2008-12-25 |
Bernd Junker |
Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
|
EP2025674A1
(fr)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
|
ES2371800T3
(es)
|
2007-09-11 |
2012-01-10 |
Kyorin Pharmaceutical Co.,Ltd. |
Cianoaminoquinolonas como inhibidores de gsk-3.
|
BRPI0816814B1
(pt)
|
2007-09-12 |
2021-08-31 |
Kyorin Pharmaceutical Co. Ltd |
Composto, composição farmacêutica e uso de um composto
|
DE102007048716A1
(de)
|
2007-10-11 |
2009-04-23 |
Merck Patent Gmbh |
Imidazo[1,2-a]pyrimidinderivate
|
TW200932219A
(en)
|
2007-10-24 |
2009-08-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
DE102007054497B3
(de)
|
2007-11-13 |
2009-07-23 |
Sanofi-Aventis Deutschland Gmbh |
Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
|
DE102008017590A1
(de)
|
2008-04-07 |
2009-10-08 |
Merck Patent Gmbh |
Glucopyranosidderivate
|
CN101555214B
(zh)
|
2008-04-08 |
2012-07-11 |
北京嘉事联博医药科技有限公司 |
苯基环丁基酰胺衍生物及其光学异构体、制备方法和用途
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
CA2975473C
(fr)
|
2008-11-13 |
2021-01-19 |
Gilead Calistoga Llc |
Therapies pour tumeurs malignes hematologiques
|
AU2009316802B2
(en)
|
2008-11-21 |
2015-02-26 |
Vtv Therapeutics Llc |
Adamantyl benzamide compounds
|
WO2010068601A1
(fr)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant
|
WO2010104205A1
(fr)
|
2009-03-11 |
2010-09-16 |
Kyorin Pharmaceutical Co., Ltd. |
7-cycloalkylaminoquinolones comme inhibiteurs de la gsk-3
|
JP2012521994A
(ja)
|
2009-03-24 |
2012-09-20 |
ギリアード カリストガ エルエルシー |
2−プリニル−3−トリル−キナゾリノン誘導体のアトロプ異性体および使用方法
|
ES2548253T3
(es)
|
2009-04-20 |
2015-10-15 |
Gilead Calistoga Llc |
Métodos para el tratamiento de tumores sólidos
|
CA2768843A1
(fr)
|
2009-07-21 |
2011-01-27 |
Gilead Calistoga Llc |
Traitement de troubles du foie par des inhibiteurs de pi3k
|
CA2771278A1
(fr)
|
2009-08-26 |
2011-03-03 |
Sanofi |
Nouveaux hydrates de fluoroglycoside heteroaromatiques cristallins, substances pharmaceutiques comprenant ces composes et leur utilisation
|
EP2482823A2
(fr)
|
2009-10-02 |
2012-08-08 |
Sanofi |
Utilisation de composés à activité inhibitrice de SGLT-1/SGLT-2 pour la production de médicament pour le traitement de maladies osseuses
|
BR112012021231A2
(pt)
|
2010-02-26 |
2015-09-08 |
Basf Plant Science Co Gmbh |
método para acentuar o rendimento em plantas, planta, construto, uso de um construto, método para a produção de uma planta transgênica, partes coletáveis de uma planta, produtos derivados de uma planta, uso de um ácido nucleíco e método para a produção de um produto
|
US20130012432A1
(en)
|
2010-02-26 |
2013-01-10 |
Novo Nordisk A/S |
Peptides for Treatment of Obesity
|
WO2011107494A1
(fr)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
|
RU2559320C2
(ru)
|
2010-03-26 |
2015-08-10 |
Ново Нордиск А/С |
Новые аналоги глюкагона
|
DE102010015123A1
(de)
|
2010-04-16 |
2011-10-20 |
Sanofi-Aventis Deutschland Gmbh |
Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
EP2582709B1
(fr)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
EP2438930A1
(fr)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Promédicaments comprenant un conjugué de liaison d'exendine
|
EP2670368A4
(fr)
|
2011-02-03 |
2015-04-15 |
Pharmedica Ltd |
Nouveaux films à dissolution orale pour administration d'insuline, pour traitement du diabète
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
WO2012120053A1
(fr)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
|
WO2012120057A1
(fr)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation
|
EP2683699B1
(fr)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
|
US8809325B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
|
WO2012120058A1
(fr)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation
|
US8809324B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
WO2012120052A1
(fr)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
AU2012234276A1
(en)
|
2011-03-28 |
2013-08-29 |
Novo Nordisk A/S |
Novel glucagon analogues
|
WO2013037390A1
(fr)
|
2011-09-12 |
2013-03-21 |
Sanofi |
Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
|
EP2567959B1
(fr)
|
2011-09-12 |
2014-04-16 |
Sanofi |
Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
|
TWI596110B
(zh)
|
2011-09-23 |
2017-08-21 |
諾佛 儂迪克股份有限公司 |
新穎升糖素類似物
|
EP2760862B1
(fr)
|
2011-09-27 |
2015-10-21 |
Sanofi |
Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
|
CA2853024C
(fr)
|
2011-11-11 |
2017-08-22 |
Pfizer Inc. |
2-thiopyrimidinones
|
WO2013134288A1
(fr)
|
2012-03-05 |
2013-09-12 |
Gilead Calistoga Llc |
Formes polymorphes de l'acide -2-(1-(9h-purine-6-ylamino)propyl)-5-fluoro-3-phénylquinazolin-4(3h)-one
|
IN2015DN03795A
(fr)
|
2012-10-24 |
2015-10-02 |
Inserm Inst Nat De La Santé Et De La Rech Médicale |
|
WO2014170496A1
(fr)
|
2013-04-18 |
2014-10-23 |
Novo Nordisk A/S |
Co-agonistes stables du récepteur du glucagon/glp -1 à action retardée et à usage médical
|
JP2017502021A
(ja)
|
2013-12-20 |
2017-01-19 |
ギリアード カリストガ エルエルシー |
ホスファチジルイノシトール3−キナーゼ阻害剤のためのプロセス方法
|
AU2014364414A1
(en)
|
2013-12-20 |
2016-06-30 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
|
CN106536547A
(zh)
|
2014-06-04 |
2017-03-22 |
诺和诺德股份有限公司 |
用于医疗用途的glp‑1/胰高血糖素受体共激动剂
|
EP3154960A1
(fr)
|
2014-06-13 |
2017-04-19 |
Gilead Sciences, Inc. |
Inhibiteurs de la phosphatidylinositol 3-kinase
|
US10426818B2
(en)
|
2015-03-24 |
2019-10-01 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Method and pharmaceutical composition for use in the treatment of diabetes
|
EP3292109A1
(fr)
|
2015-05-05 |
2018-03-14 |
Pfizer Inc |
2-thiopyrimidinones
|
CN111032680A
(zh)
|
2017-03-15 |
2020-04-17 |
诺和诺德股份有限公司 |
能够与黑皮质素4受体结合的双环化合物
|
WO2019219714A1
(fr)
|
2018-05-15 |
2019-11-21 |
Novo Nordisk A/S |
Composés capables de se lier au récepteur de la mélanocortine 4
|
WO2020053414A1
(fr)
|
2018-09-14 |
2020-03-19 |
Novo Nordisk A/S |
Composés bicycliques aptes à se lier aux agonistes du récepteur de la mélanocortine 4
|
CN110128309A
(zh)
*
|
2019-06-13 |
2019-08-16 |
郑州大学 |
一种新型的2-巯基异丁酸制备方法
|